IceCure Medical yesterday said it received Israeli AMAR authorization to use its freezing technology in specific indications.
The approval will allow the Israel-based company to use the technology to freeze benign and malignant tumors, including breast, lungs, bones, liver, lymphatic tissue, lymph nodes and endocrine glands.